JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

148.21

+0.39%↑

Home・Lista de Ações・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Fechado

SetorSaúde

30.23 2.44

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

29.85

Máximo

30.28

Indicadores-chave
By Trading Economics
Rendimento	-5.8M 40M
Vendas	16M 200M
P/E Médio do Setor	8.367 37.461
EPS	0.92
Margem de lucro	19.839
Funcionários	268
EBITDA	3M 59M

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+47.31% upside

Dividendos
By Dow Jones
Próximos Ganhos	28 de out. de 2025

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-544M 1.5B
Abertura anterior	27.79
Fecho anterior	30.23

Sentimento de Notícias

By Acuity

61%

39%

309 / 373 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

29.8 / N/A Suporte e Resistência

Harmony Biosciences Holdings Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

26 de out. de 2025, 23:52 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

26 de out. de 2025, 23:52 UTC

Conversa de Mercado

Nikkei May Rise on Weaker Yen -- Market Talk

26 de out. de 2025, 23:46 UTC

Conversa de Mercado

Oil Rises Amid Ongoing Supply Concerns -- Market Talk

26 de out. de 2025, 23:41 UTC

Conversa de Mercado

Gold Falls; U.S.-China Trade Deal Optimism Overcomes Signs of Cooler U.S. Inflation -- Market Talk

26 de out. de 2025, 23:34 UTC

Ganhos

Sinopharm Group 9-Mos Oper Pft CNY10.87B Vs. Pft CNY10.84B >1099.HK

26 de out. de 2025, 23:32 UTC

Ganhos

Sinopharm Group 9-Mos Net CNY5.31B Vs. Net CNY5.28B >1099.HK

26 de out. de 2025, 23:30 UTC

Ganhos

Sinopharm Group 9-Mos Rev CNY431.48B Vs. CNY442.42B >1099.HK

26 de out. de 2025, 22:29 UTC

Ganhos

WuXi AppTec 3Q Rev CNY12.06B ; up 15.3% on Year>603259.SH

26 de out. de 2025, 22:29 UTC

Ganhos

WuXi AppTec: Higher Contributions From Contract Research Development and Manufacturing Organization Unit Supported Results>603259.SH

26 de out. de 2025, 22:29 UTC

Ganhos

WuXi AppTec: Results Also Boosted From Divestment Gains >603259.SH

26 de out. de 2025, 22:29 UTC

Ganhos

WuXi AppTec 3Q Net CNY5.13B ; up 82.9% on Year>603259.SH

26 de out. de 2025, 22:16 UTC

Ganhos

Stock Futures Rise Ahead of Mag 7 Earnings, Fed Decision -- Barrons.com

26 de out. de 2025, 21:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Novartis Agrees to Acquire Avidity Biosciences for $12 Billion -- WSJ

26 de out. de 2025, 19:29 UTC

Aquisições, Fusões, Aquisições de Empresas

Novartis Deal Values Avidity Biosciences At $12 Billion -- Barrons.com

26 de out. de 2025, 06:39 UTC

Ganhos

CITIC Securities 3Q Rev CNY22.78B Vs. CNY15.96B >6030.HK

26 de out. de 2025, 06:39 UTC

Ganhos

CITIC Securities: Higher Income From Brokerage, Investment Banking Supported Results>6030.HK

26 de out. de 2025, 06:39 UTC

Ganhos

CITIC Securities 3Q Net CNY9.44B Vs. Net CNY6.23B >6030.HK

24 de out. de 2025, 21:24 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

24 de out. de 2025, 21:24 UTC

Conversa de Mercado

Moody's Sees France With Increased Risk of Political Dysfunction -- Market Talk

24 de out. de 2025, 21:07 UTC

Ganhos

The Score: Netflix, Amazon.com, Six Flags and More Stocks That Defined the Week -- WSJ

24 de out. de 2025, 20:58 UTC

Ganhos

S&P 500 Climbs to New Record on Strong Earnings -- WSJ

24 de out. de 2025, 20:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

24 de out. de 2025, 20:40 UTC

Ganhos

Intel Expects Chip Shortages on Better PC Demand. Here's Why AMD Is Winning Too. -- Barrons.com

24 de out. de 2025, 20:24 UTC

Ganhos

General Dyamics Stock Rises on Earnings. Aerospace Was a Standout. -- Barrons.com

24 de out. de 2025, 20:23 UTC

Ganhos

General Dyamics Stock Rises on Earnings. Aerospace Was a Standout. -- Barrons.com

24 de out. de 2025, 20:13 UTC

Ganhos

These Stocks Moved the Most Today: Intel, AMD, Ford, Deckers, Newmont, Nextracker, Booz Allen, Coinbase, and More -- Barrons.com

24 de out. de 2025, 20:07 UTC

Conversa de Mercado

Different-Cell Imputation Rose Proportionally in September CPI -- Market Talk

24 de out. de 2025, 19:40 UTC

Conversa de Mercado

Treasury Yields Mixed, Dollar Stronger Ahead of Fed Week -- Market Talk

24 de out. de 2025, 19:35 UTC

Conversa de Mercado

Oil Rally on U.S. Russia Sanctions Loses Steam -- Market Talk

24 de out. de 2025, 19:33 UTC

Ganhos

IBM and Google Are Also Making Moves in Quantum. Don't Count Out the Bigger Players. -- Barrons.com

Comparação entre Pares

Variação de preço

Harmony Biosciences Holdings Inc Previsão

Preço-alvo

By TipRanks

47.31% parte superior

Previsão para 12 meses

Média 44.56 USD 47.31%

Máximo 62 USD

Mínimo 31 USD

Com base em 10 analistas de Wall Street que oferecem metas de preço de 12 meses para Harmony Biosciences Holdings Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

10 ratings

Comprar

Manter

Vender

Com base em 10 analistas que deram avaliações de ações para Harmony Biosciences Holdings Inc - Dist nos últimos 3 meses.

Pontuação Técnica

By Trading Central

29.8 / N/ASuporte e Resistência

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentimento

By Acuity

309 / 373 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.